Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal 2021 Financial Results and Recent Business Developments
Aspen Aerogels (ASPN) reported a 21% revenue growth in 2021, totaling $121.6 million, but faced a net loss of $37.1 million. Q4 revenue was $31.5 million, up from $23.0 million a year prior, yet net loss increased to $16.4 million from $6.2 million. The company anticipates 2022 revenue between $145 million and $155 million, with a projected loss of $66.7 million to $70.7 million. Aspen is expanding its manufacturing capabilities in Georgia, aiming for $1.35 billion in annual revenue capacity. They expect to double revenue by 2023 and triple it by 2025.
- Revenue growth of 21% in 2021 to $121.6 million.
- Initiated shipments of PyroThin thermal barriers to major automotive customers.
- Plans for a second manufacturing facility in Georgia with $1.35 billion revenue capacity.
- Projected revenue growth to $145-$155 million in 2022, with strong demand in the EV market.
- Net loss of $37.1 million in 2021, higher than $21.8 million in 2020.
- Increased net loss in Q4 to $16.4 million from $6.2 million year-over-year.
- Projected net loss for 2022 between $66.7 million and $70.7 million.
- Adjusted EBITDA loss of $(26.0) million for the full year 2021.
NORTHBOROUGH, Mass., Feb. 17, 2022 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" "the Company"), a technology leader in sustainability and electrification solutions, today announced financial results for the fourth quarter and full year 2021, which ended December 31, 2021, and discussed recent business developments.
Total revenue for the fourth quarter was
Total revenue for the full year was
Adjusted EBITDA for the fourth quarter was
2021 Highlights and Recent Business Developments
- Total revenue grew
21% during 2021 to$121.6 million - Generated
$6.7 million of PyroThin® thermal barrier revenue in 2021 from 10 customers - Commenced shipment of PyroThin production parts to our major U.S. and Asian automotive customers
- Selected Statesboro, Georgia as site for 2nd manufacturing plant with
$1.35 billion in annual revenue capacity - Agreed to
$100.0 million convertible note and$50.0 million equity placement with Koch Strategic Platforms
Don Young, Aspen's President and CEO, noted, "Our business continues to accelerate and we are pleased with the increasing market adoption of our high-performance thermal solutions. Aspen's 2021 revenue growth of
"To support our PyroThin thermal barrier and carbon aerogel battery materials businesses, we also significantly increased the level of our investment during the year in personnel, infrastructure and related activities," Mr. Young continued. "The combination of these planned investments and the COVID related production constraints during the year contributed to a decrease in Adjusted EBITDA and an increase in net loss versus 2020."
"We made considerable progress in the development of our PyroThin thermal barrier business," emphasized Mr. Young. "We began shipments of production parts to our major U.S. and Asian automotive customers during the fourth quarter and delivered
Mr. Young added, "On February 15, 2022, we agreed to terms on a
2022 Financial Outlook
Aspen issues its 2022 full year outlook as follows:
- Total revenue is expected to range between
$145.0 million and$155.0 million - Net loss is expected to range between
$66.7 million and$70.7 million - Adjusted EBITDA is expected to range between
$(42.0) million and$(46.0) million - Net loss per share is expected to range between
$1.95 and$2.07
Our 2022 outlook assumes depreciation and amortization of
Mr. Young commented, "We are projecting solid revenue growth in each of our principal markets during 2022, including a tripling of our EV thermal barrier revenue to
Mr. Young continued, "While these planned investments will expand our Adjusted EBITDA loss and net loss in 2022 versus 2021, they position us for strong growth in revenue and profitability through the decade. Based on customer forecasts and our thermal barrier quoting activity, we are targeting to double our revenue to nearly
A reconciliation of non-GAAP Adjusted EBITDA to net loss for the 2022 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Aspen Aerogels may incur charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2022, including those related to the planned capacity expansion, that could cause actual results to vary materially from this outlook.
Statesboro, Georgia Manufacturing Facility
Earlier today, Aspen announced the selection of a 90-acre parcel in Statesboro, Georgia as the site for its planned 500,000-square-foot advanced manufacturing facility. Combined with Aspen's original East Providence, Rhode Island plant, the planned state-of-the-art facility in Georgia will be designed to triple Aspen's aerogel capacity in support of the Company's thermal barrier expansion plans in the fast-growing electric vehicle market. The Company expects to have the second plant operational late in the second half of 2023.
"We believe our Statesboro investment plan offers attractive potential returns to our investors," remarked Mr. Young. "At full capacity, we project the Statesboro facility alone can produce thermal barriers for 4.4 million electric vehicles per year and support more than
"We are planning to invest nearly
Mr. Young concluded, "At full capacity in East Providence and Statesboro, we project we will have the ability to generate gross margins of approximately
Conference Call Notification
A conference call with Aspen management to discuss fourth quarter and fiscal 2021 results and recent business developments will be held at 5:00 pm ET on February 17, 2022. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed. Shareholders and other interested parties may call 844-200-6205 (toll free, U.S. & Canada only) or +1 929-526-1599 (international) and reference passcode "651046" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.
Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.
Management believes that these non-GAAP financial measures reflect Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as they exclude expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.
The non-GAAP financial measures do not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly-filed reports in their entirety and not rely on any single financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability. The company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle market. The company's carbon aerogel program seeks to increase the performance of lithium-ion battery cells to enable EV manufacturers to extend the driving range and reduce the cost of electric vehicles. Aspen's Spaceloft® products provide building owners with industry-leading energy efficiency and fire safety. The company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its aerogel technology platform into additional high-value markets. Headquartered in Northborough, Mass., Aspen manufactures its products at its East Providence, R.I. facilities. For more information, please visit www.aerogel.com.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's 2021 financial outlook. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's 2021 financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's expectations about capacity, revenue, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net loss, Adjusted EBITDA, Adjusted EBITDA margin and related decreases, improvements, timing, variability or trends; beliefs about the general strength, weakness or health of Aspen's business; beliefs about current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; beliefs about the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the COVID-19 pandemic and its impact on Aspen's operating performance; beliefs about Aspen's strategic initiatives and implementation; beliefs about Aspen's investments in the electric vehicle market and aerogel technology platform; beliefs about the potential to develop new, high-value market opportunities from Aspen's aerogel technology platform; beliefs about the commercial potential of new aerogel products, technologies, businesses and partnerships; beliefs about the role of Aspen's technology and opportunities in the electric vehicle market; beliefs about Aspen's ability to provide and deliver products and services to electric vehicle customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's electric vehicle opportunities, including the EV thermal barrier business; beliefs about the performance of PyroThin including its ability to mitigate the propagation of thermal runaway in electric vehicles; beliefs about Aspen's ability to expand the market for PyroThin, to achieve design wins, to commence shipments of production parts, and to become an industry standard solution for thermal runaway management; beliefs about Aspen's thermal barrier design, prototype, quoting and fabrication activities; beliefs about Aspen's ability to deliver broader solutions to enhance electric vehicle battery performance and safety; beliefs about Aspen's ability to develop and commercialize carbon aerogel battery materials in the lithium-ion or solid state battery markets; beliefs about Aspen's automated thermal barrier fabrication capability; beliefs about the expansion of Aspen's silica aerogel blanket manufacturing capacity in Statesboro, Georgia, or any other location, including the timing, size, cost, capacity, job creation and operating benefits of any such expansion; beliefs about the construction of Aspen's Advanced Thermal Barrier Center; beliefs about the expansion of Aspen's battery materials facilities or carbon aerogel capacity; beliefs about the sufficiency of Aspen's financial resources and liquidity; beliefs about the KSP convertible note or equity financings; beliefs about Aspen's ability to raise the capital required to fund operating requirements, expansions of manufacturing or fabrication capacity; beliefs about Aspen's ability to execute its strategy; future operating performance on an annual or other basis; and accounting and other assumptions involved in arriving at the expectations. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: an inability to create new product, partnership and market opportunities; any sustained downturn in the energy industry or energy prices; any sustained downturn in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets due to the coronavirus pandemic, COVID-19 or any other factor; any failure to sustain project-based demand in the subsea, LNG, on-shore or other markets; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; any failure of Aspen or PyroThin to meet contractual specifications and requirements under contracts with EV thermal barrier customers; Aspen's inability to create new product, customer or market opportunities, including for PyroThin, battery performance and safety products, battery materials or for other new products developed from Aspen's aerogel technology; any disruption or inability to achieve expected capacity levels in any of our three existing production lines in East Providence, RI or the manufacturing facility in which they are located, including due to the coronavirus pandemic, COVID-19 or any other factor; any inability to expand manufacturing capacity in a second manufacturing facility in Statesboro, Georgia or at any other location; any inability to establish automated thermal barrier fabrication operations in Mexico or any other location; the failure to receive all regulatory or other approvals required to operate, maintain or expand Aspen's facilities; any failure of demand for Aspen's products; any failure to achieve expected price increases or average selling prices for Aspen's products; any significant increase in the cost of raw materials, utilities or any other manufacturing consumable; shortages of raw materials, utilities or any other manufacturing consumable due to the coronavirus pandemic, COVID-19 or any other factor; the failure to generate sufficient operating cash flow or to obtain significant additional capital to pursue Aspen's strategy; the failure of Aspen's products to become widely adopted; the competition Aspen faces in its business; any failure to enforce any of Aspen's patents; any failure to protect or expand Aspen's aerogel technology platform; any future finding of invalidity of any patent in any jurisdiction; any failure to generate sufficient operating cash flow or to obtain sufficient additional capital to continue to pursue Aspen's new business, technology, patent enforcement, or patent defense strategy; any failure of Aspen's products to meet applicable specifications and other performance, safety, technical and delivery requirements; the general economic conditions and cyclical demands in the markets that Aspen serves; the economic, operational and political risks associated with sales and expansion of operations in foreign countries; the loss of any direct customer, including distributors, contractors and OEMs; compliance with health and safety laws and regulations; the maintenance and development of distribution channels; and the other risk factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020 and filed with the Securities and Exchange Commission ("SEC") on March 12, 2021, as well as any updates to those risk factors filed from time to time in our subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.
ASPEN AEROGELS, INC. | ||||||||
December 31, | December 31, | |||||||
2021 | 2020 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 76,564 | $ | 16,496 | ||||
Accounts receivable, net | 20,426 | 15,698 | ||||||
Inventories | 11,987 | 13,099 | ||||||
Prepaid expenses and other current assets | 3,173 | 1,830 | ||||||
Total current assets | 112,150 | 47,123 | ||||||
Property, plant and equipment, net | 55,778 | 46,739 | ||||||
Operating lease right-of-use assets | 13,531 | 3,478 | ||||||
Other long-term assets | 1,495 | 84 | ||||||
Total assets | $ | 182,954 | $ | 97,424 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 17,440 | $ | 5,351 | ||||
Accrued expenses | 10,819 | 3,884 | ||||||
Current portion of long-term debt | — | 1,609 | ||||||
Deferred revenue | 1,321 | 2,037 | ||||||
Operating lease liabilities | 2,247 | 1,046 | ||||||
Current prepayment liability | 4,728 | — | ||||||
Total current liabilities | 36,555 | 13,927 | ||||||
Prepayment liability | 5,000 | 9,555 | ||||||
Long-term debt | — | 2,059 | ||||||
Operating lease liabilities long-term | 12,991 | 3,597 | ||||||
Other long-term liabilities | — | 434 | ||||||
Total liabilities | 54,546 | 29,572 | ||||||
Stockholders' equity: | ||||||||
Total stockholders' equity | 128,408 | 67,852 | ||||||
Total liabilities and stockholders' equity | $ | 182,954 | $ | 97,424 | ||||
ASPEN AEROGELS, INC. | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Revenue: | ||||||||||||||||
Product | $ | 31,303 | $ | 23,062 | $ | 121,112 | $ | 99,834 | ||||||||
Research services | 172 | (44) | 510 | 439 | ||||||||||||
Total revenue | 31,475 | 23,018 | 121,622 | 100,273 | ||||||||||||
Cost of revenue: | ||||||||||||||||
Product | 33,093 | 19,142 | 111,552 | 85,545 | ||||||||||||
Research services | 48 | 13 | 133 | 134 | ||||||||||||
Gross profit | (1,666) | 3,863 | 9,937 | 10,731 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 3,313 | 2,293 | 11,441 | 8,729 | ||||||||||||
Sales and marketing | 4,797 | 2,702 | 16,581 | 11,753 | ||||||||||||
General and administrative | 6,536 | 4,999 | 22,514 | 15,681 | ||||||||||||
Total operating expenses | 14,646 | 9,994 | 50,536 | 36,163 | ||||||||||||
Loss from operations | (16,312) | (6,131) | (40,599) | (21,569) | ||||||||||||
Interest expense, net | (41) | (58) | (229) | (240) | ||||||||||||
Gain on extinguishment of debt | — | — | 3,734 | — | ||||||||||||
Total other income (expense) | (41) | (58) | 3,505 | (240) | ||||||||||||
Net loss | $ | (16,353) | $ | (6,189) | $ | (37,094) | $ | (21,809) | ||||||||
Net loss per share: | ||||||||||||||||
Basic and diluted | (0.50) | (0.23) | (1.22) | (0.83) | ||||||||||||
Weighted-average common shares outstanding: | ||||||||||||||||
Basic and diluted | 32,650,411 | 27,054,956 | 30,433,154 | 26,377,652 | ||||||||||||
Square Foot Operating Metric
We price our product and measure our product shipments in square feet.
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(In thousands) | ||||||||||||||||
Product shipments in square feet | 7,451 | 6,328 | 34,977 | 28,635 | ||||||||||||
Reconciliation of Non-GAAP Financial Measures
The following tables presents a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net Income (Loss)
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance. These other items include a gain on the extinguishment of debt during the year ended December 31, 2021.
For the three and twelve months ended December 31, 2021 and 2020:
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(In thousands) | ||||||||||||||||
Net loss | $ | (16,353) | $ | (6,189) | $ | (37,094) | $ | (21,809) | ||||||||
Depreciation and amortization | $ | 2,584 | 2,528 | 9,440 | 10,198 | |||||||||||
Stock-based compensation | $ | 1,576 | 2,014 | 5,176 | 5,004 | |||||||||||
Gain on extinguishment of debt | $ | — | — | (3,734) | — | |||||||||||
Interest expense, net | $ | 41 | 58 | 229 | 240 | |||||||||||
Adjusted EBITDA | $ | (12,152) | $ | (1,589) | $ | (25,983) | $ | (6,367) | ||||||||
For the 2022 full year financial outlook:
Year Ending | ||||||||
December 31, 2022 | ||||||||
Low | High | |||||||
(In thousands) | ||||||||
Net loss | (70,700) | (66,700) | ||||||
Depreciation and amortization | 9,700 | 9,700 | ||||||
Stock-based compensation | 8,200 | 8,200 | ||||||
Interest expense, net | 6,800 | 6,800 | ||||||
Adjusted EBITDA | $ | (46,000) | $ | (42,000) | ||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-fourth-quarter-and-fiscal-2021-financial-results-and-recent-business-developments-301485201.html
SOURCE Aspen Aerogels, Inc.
FAQ
What were Aspen Aerogels' earnings results for Q4 2021?
What is the full-year financial outlook for Aspen Aerogels in 2022?
How did Aspen Aerogels perform financially in 2021?
What are Aspen Aerogels' growth projections for the coming years?
